Stay updated with breaking news from Rev Anticancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beyond issuing guidance documents, what actions has the FDA taken to ensure inclusion of relevant patient populations in cancer clinical trials? And...
This review summarizes progress in the development of peptide-based nanovaccines against HPV infection.
Liquid biopsy is becoming more and more promising for solid tumour research, detection and surveillance. Here, Lab News asks Dr Han Wei what liquid...
GLOW study presented as a late-breaking abstract at the European Hematology Association (EHA) Virtual CongressBEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVI...
GLOW study presented as a late-breaking abstract at the European Hematology Association (EHA) Virtual Congress The Janssen Pharmaceutical Companies of Johnson Johnson today announced primary results